NEW YORK (GenomeWeb) – Veracyte reported after the close of the market on Tuesday that its fourth quarter 2017 revenues increased 7 percent compared to the fourth quarter 2016.

For the three months ended Dec. 31, 2017, the genomic testing firm reported total revenues of $19.6 million, compared to $18.3 million in Q4 2016, and just beating the analysts' average estimate of $19.0 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.